Theragen Health, a subsidiary of Lotte Healthcare, said it has recently opened a new microbiome lab in Pankyo in Seongnam, Gyeonggi Province, significantly expanding its capabilities in the field of microbial analysis.The laboratory is equipped to handle up to 100,000 DNA samples annually.The microb
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have manufactured a novel bio-scaffold that exhibits electrical signals when pressure is applied, accelerating bone regeneration.Bone healing is complex, and conventional methods like bone grafting and growth factor delive
The Korean Health Industry Development Institute (KHIDI) said it has started accepting applications from Korean healthcare companies that want to move into its Boston Connect and Development (C&D) Incubation Office, located within the Cambridge Innovation Center (CIC) in Boston, Mass. KHIDI will acc
Researchers at the Korea Research Institute of Bioscience & Biotechnology (KRIBB) have successfully developed a gene therapy for hereditary spastic paraplegia (HSP), a rare, incurable disorder.HSP, a genetic neurological condition, leads to progressive stiffness and weakness in the legs, eventually
As the healthcare investment landscape undergoes rapid transformation in 2024, industry experts highlight emerging trends and strategic approaches to capitalizing on these changes.The focus is particularly on the increasing prominence of GLP-1 drugs in obesity treatment, significant mergers and acqu
Boehringer Ingelheim Korea said it has appointed Ana-Maria Boie as the new general manager (GM) and head of human pharma, effective from Jan. 15.According to the company, Ana-Maria Boie, the newly appointed GM, has worked in the pharmaceutical industry for 24 years and has amassed expertise in manag
Seegene announced a strategic collaboration with Microsoft to advance molecular diagnostics solutions to better diagnose and treat diseases.Under the accord, Seegene and Microsoft's Global Healthcare Team will jointly participate in annual symposiums for technology-sharing, connect with current and
Korean medical device firms have been actively engaging in mergers and acquisitions (M&A) since the start of the year, aiming to maximize synergies and create new growth drivers.Notably, these companies are adopting diverse strategies, including acquiring businesses outside their primary sectors, in
Dong-A ST said it has partnered with the Korea Institute of Science and Technology (KIST) to develop a novel treatment for inflammatory bowel disease (IBD).Under the accord, Dong-A ST will acquire the patent rights for the oral nucleic acid therapy delivery technology developed by KIST's Biomedical
Severance Hospital has developed an artificial intelligence (AI) model capable of rapidly and accurately diagnosing sepsis and predicting patient outcomes.Sepsis, a critical condition resulting from an abnormal body response to infection leading to major organ dysfunction, has high incidence and mor
AriBio, primarily known for its work to develop an oral Alzheimer's disease treatment candidate, has been penalized for the sale of cosmetics containing ingredients that are not permitted for use.The Ministry of Food and Drug Safety issued the penalty last Thursday, mandating a three-month suspensio
Samsung Bioepis, a subsidiary of Samsung Biologics, said it has received product approval from the Ministry of Food and Drug Safety for Epiruscly, a biosimilar referencing Soliris, last Friday.Soliris, developed by AstraZeneca's subsidiary Alexion Pharmaceuticals, is a high-cost biopharmaceutical fo
A research team at the Korea Institute of Science and Technology (KIST), in partnership with Seoul National University (SNU) and Kyung Hee University, developed a new drug delivery system that could better treat retinal diseases.Retinal diseases, such as age-related macular degeneration and retiniti
Merck Korea said it launched its Fertility Benefit Program for its employees and their spouses, effective from Jan. 1 this year.Merck Korea has about 1,750 employees, according to its website. The program, part of Merck's broader initiative "Fertility Counts," is designed to support the reproductive
Lotte Biologics said it has entered into a strategic partnership with NJ Bio, a U.S. contract research organization (CRO), to enhance antibody-drug conjugate (ADC) services.Established in 2018 and based in New Jersey, NJ Bio specializes in integrated chemical and biological services for linker paylo
Korea is currently facing a significant ethical and legal dilemma in its medical sector due to increasing instances of doctors performing surgeries while under the influence of alcohol.This issue gained national attention following an incident in January, where a young surgeon in Seoul conducted fac
GC Biopharma said that the intracerebroventricular (ICV) enzyme replacement therapy (ERT) drug for Sanfilippo Syndrome Type A, jointly developed with Korean biotech venture Novel Pharma, has been designated as an orphan drug by the European Medicines Agency (EMA).The recognition follows the drug's p
Nestled in the Eunpyeong-gu, northwestern Seoul, Eunpyeong St. Mary's Hospital has become an important center for healthcare and community service as it approaches its fifth anniversary.Established to deliver comprehensive medical care, the hospital is particularly known for cardiac care, neurology,
Dongwha Pharm said it acquired four over-the-counter (OTC) products from Celltrion, which the latter purchased from Takeda Pharmaceuticals in 2020, for about 37.2 billion won ($27.8 million).The transaction includes medications such as the comprehensive cold medicine Whituben and Whituben Nasal Spra
CanariaBio said the Data and Safety Monitoring Board (DSMB) recommended halting its global phase 3 clinical trial of oregovomab, an antibody targeting CA125, for ovarian cancer patients.The company said that the recommendation was made due to the trial not achieving the necessary statistical value (